Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
NCT02463682 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2016-04-11
Summary
This is a feasibility study of an artificial pancreas (AP) system with our previously validated Zone-MPC and Health Monitoring System (HMS) algorithms (ClinicalTraisl.gov: NCT01929798) integrated into the Diabetes Assistant (DiAs) system.
Conditions
- Diabetes Mellitus, Type 1
Interventions
- DEVICE
-
CGM and Insulin Pump
Dexcom G4 Platinum CGM with Share AP Receiver Roche Accu-Chek insulin pump
- DEVICE
-
Closed-Loop Control System
The devices that will be used in the Closed-Loop Control System include the following components: DiAs - a smart-phone medical platform; Dexcom Dexcom G4 Platinum connected to DiAs via Bluetooth CGM receiver; Roche Accu-Chek insulin pump connected to DiAs via wireless Bluetooth; Remote Monitoring Server connected to DiAs via 3G or local Wi-Fi network, and Zone-MPC and HMS algorithms running on DiAs (MPC and HMS)
Sponsors & Collaborators
-
University of California, Santa Barbara
collaborator OTHER - collaborator OTHER
-
University of Virginia
collaborator OTHER -
University of Padova
collaborator OTHER -
Sansum Diabetes Research Institute
lead OTHER
Principal Investigators
-
Francis J Doyle III, PhD · University of California, Santa Barbara/William Sansum Diabetes Center
-
Eyal Dassau, PhD · University of California, Santa Barbara/William Sansum Diabetes Center
-
Jordan E Pinsker, MD · Sansum Diabetes Research Institute
-
Ananda Basu, MD · Mayo Clinic, Rochester, MN
-
Yogish Kudva, MD · Mayo Clinic, Rochester, MN
-
Boris Kovatchev, PhD · University of Virginia
-
Sue Brown, MD · University of Virginia
-
Stephen Patek, PhD · University of Virginia
-
Claudio Cobelli, PhD · University of Padova
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2015-10-31
- Completion
- 2015-10-31
Countries
- United States
Study Locations
More Related Trials
-
Examining The Role of CGM in T2DM
NCT01614262 ·Status: COMPLETED ·Phase: NA
-
Real-time Continuous Glucose Monitoring
NCT03326232 ·Status: UNKNOWN ·Phase: NA
-
Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 Diabetes
NCT01653210 ·Status: COMPLETED
-
Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy
NCT03761615 ·Status: COMPLETED
-
Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers
NCT07063420 ·Status: RECRUITING ·Phase: NA
-
Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (France)
NCT01742741 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Continuous Glucose Monitor in Hospitalized, Post-operative Patients With Diabetes Mellitus
NCT04845685 ·Status: SUSPENDED ·Phase: NA
-
Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus
NCT04905628 ·Status: UNKNOWN
-
Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM
NCT05714059 ·Status: COMPLETED ·Phase: NA
-
Reducing Emergency Department Visits and Improving Glucose Control in Uncontrolled Type 2 Diabetes Using CGM Sensors at Hospital Discharge
NCT04277780 ·Status: TERMINATED ·Phase: NA
-
Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy
NCT02556554 ·Status: COMPLETED ·Phase: NA
-
Managing Diabetes During Pregnancy in the Wireless Age
NCT01474525 ·Status: UNKNOWN ·Phase: NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
NCT06628453 ·Status: RECRUITING ·Phase: NA
-
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy
NCT06957028 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes Mellitus
NCT04847219 ·Status: COMPLETED ·Phase: NA
-
Effect of Switching From Intermittently Scanned to Real-time Continuous Glucose Monitoring on Diabetes Management in Adults With Type 2 Diabetes (Switch CGM T2D)
NCT06805786 ·Status: RECRUITING
-
CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2))
NCT04756141 ·Status: COMPLETED ·Phase: NA
-
Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes
NCT02282397 ·Status: COMPLETED ·Phase: NA
-
Dexcom G6 Intervention Study
NCT03877068 ·Status: COMPLETED ·Phase: NA
-
Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward
NCT04871958 ·Status: TERMINATED ·Phase: NA
-
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
NCT01548222 ·Status: COMPLETED
-
Temporary Use of a Continuous Glucose Monitoring System as an Adjunct to Lifestyle Medicine Education
NCT04306848 ·Status: WITHDRAWN ·Phase: NA
-
AI-Assisted Insulin Titration System on Inpatients Glucose Control
NCT04517201 ·Status: UNKNOWN ·Phase: NA
-
The Use of a Continuous Glucose Monitoring System (Dexcom G6) in Hospitalized Patients for Acute Care
NCT04385862 ·Status: WITHDRAWN
-
Feasibility Study of PID Versus MPC and HMS
NCT01987206 ·Status: COMPLETED ·Phase: EARLY_PHASE1